ContraVir Pharmaceuticals Inc. (Nasdaq: CTRV) priced its public offering at the discounted price of $1.00 per unit sending the stock price down 32 cents to close at $0.86.
ContraVir Pharmaceuticals prices offering
April 25, 2017 at 17:09 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|